Sika Valuation

Is SIKAZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SIKAZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SIKAZ (CHF230.9) is trading below our estimate of fair value (CHF270.3)

Significantly Below Fair Value: SIKAZ is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for SIKAZ?

Key metric: As SIKAZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SIKAZ. This is calculated by dividing SIKAZ's market cap by their current earnings.
What is SIKAZ's PE Ratio?
PE Ratio29.8x
EarningsCHF 1.25b
Market CapCHF 37.12b

Price to Earnings Ratio vs Peers

How does SIKAZ's PE Ratio compare to its peers?

The above table shows the PE ratio for SIKAZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.4x
CRDA Croda International
30.4x15.1%UK£4.9b
JMAT Johnson Matthey
23.8x28.4%UK£2.6b
VCT Victrex
24.9x37.8%UK£763.5m
TET Treatt
22.6x15.3%UK£255.9m
SIKAZ Sika
29.8x8.9%CHF 37.1b

Price-To-Earnings vs Peers: SIKAZ is expensive based on its Price-To-Earnings Ratio (29.8x) compared to the peer average (25.4x).


Price to Earnings Ratio vs Industry

How does SIKAZ's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SIKAZ is expensive based on its Price-To-Earnings Ratio (29.8x) compared to the European Chemicals industry average (16.8x).


Price to Earnings Ratio vs Fair Ratio

What is SIKAZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SIKAZ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio29.8x
Fair PE Ratio19.6x

Price-To-Earnings vs Fair Ratio: SIKAZ is expensive based on its Price-To-Earnings Ratio (29.8x) compared to the estimated Fair Price-To-Earnings Ratio (19.6x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SIKAZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 230.90
CHF 288.67
+25.0%
11.9%CHF 350.00CHF 220.00n/a21
Nov ’25CHF 243.00
CHF 291.76
+20.1%
13.0%CHF 370.00CHF 220.00n/a21
Oct ’25CHF 276.90
CHF 298.48
+7.8%
12.4%CHF 370.00CHF 230.00n/a21
Sep ’25CHF 273.40
CHF 296.00
+8.3%
12.8%CHF 380.00CHF 230.00n/a22
Aug ’25CHF 267.20
CHF 295.00
+10.4%
13.0%CHF 380.00CHF 230.00n/a22
Jul ’25CHF 254.90
CHF 295.68
+16.0%
12.8%CHF 380.00CHF 230.00n/a22
Jun ’25CHF 275.20
CHF 294.48
+7.0%
13.1%CHF 380.00CHF 230.00n/a21
May ’25CHF 263.20
CHF 293.76
+11.6%
13.2%CHF 380.00CHF 230.00n/a21
Apr ’25CHF 269.50
CHF 290.85
+7.9%
14.6%CHF 390.00CHF 224.00n/a20
Mar ’25CHF 258.45
CHF 288.19
+11.5%
14.5%CHF 390.00CHF 224.00n/a21
Feb ’25CHF 239.45
CHF 285.10
+19.1%
15.2%CHF 390.00CHF 230.00n/a21
Jan ’25CHF 273.70
CHF 283.19
+3.5%
16.1%CHF 380.00CHF 225.00n/a21
Dec ’24CHF 236.00
CHF 281.10
+19.1%
16.6%CHF 380.00CHF 223.00n/a21
Nov ’24CHF 215.90
CHF 282.43
+30.8%
16.2%CHF 380.00CHF 223.00CHF 243.0021
Oct ’24CHF 233.30
CHF 298.50
+27.9%
12.9%CHF 380.00CHF 230.00CHF 276.9021
Sep ’24CHF 247.10
CHF 300.09
+21.4%
13.0%CHF 380.00CHF 228.00CHF 273.4022
Aug ’24CHF 270.40
CHF 300.00
+10.9%
13.8%CHF 390.00CHF 228.00CHF 267.2021
Jul ’24CHF 256.10
CHF 304.05
+18.7%
14.8%CHF 390.00CHF 228.00CHF 254.9021
Jun ’24CHF 248.30
CHF 298.88
+20.4%
14.3%CHF 390.00CHF 228.00CHF 275.2021
May ’24CHF 245.60
CHF 295.43
+20.3%
14.3%CHF 390.00CHF 228.00CHF 263.2020
Apr ’24CHF 255.10
CHF 293.95
+15.2%
17.3%CHF 390.00CHF 162.95CHF 269.5022
Mar ’24CHF 260.30
CHF 292.13
+12.2%
17.6%CHF 390.00CHF 162.95CHF 258.4522
Feb ’24CHF 258.80
CHF 277.59
+7.3%
16.4%CHF 380.00CHF 162.95CHF 239.4522
Jan ’24CHF 222.30
CHF 280.81
+26.3%
20.0%CHF 420.00CHF 162.95CHF 273.7021
Dec ’23CHF 244.40
CHF 281.00
+15.0%
20.0%CHF 420.00CHF 162.95CHF 236.0021
Nov ’23CHF 222.90
CHF 280.02
+25.6%
20.2%CHF 420.00CHF 162.95CHF 215.9021

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies